INTRATHECAL CHEMOTHERAPY

Clinical trials for INTRATHECAL CHEMOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new INTRATHECAL CHEMOTHERAPY trials appear

Sign up with your email to follow new studies for INTRATHECAL CHEMOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Spinal chemo shows promise in stopping brain spread of aggressive lymphoma

Prevention Completed

This study tested a chemotherapy drug called thiotepa, given directly into the spinal fluid, to prevent a type of aggressive lymphoma (DLBCL) from spreading to the brain or spinal cord. It involved 31 high-risk adults and tracked how many developed brain involvement over two year…

Matched conditions: INTRATHECAL CHEMOTHERAPY

Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Prevention

Last updated May 15, 2026 11:54 UTC

INTRATHECAL CHEMOTHERAPY

Get alerted when new INTRATHECAL CHEMOTHERAPY trials appear

Spinal chemo shows promise in stopping brain spread of aggressive lymphoma